CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift Director gave 3,932,903 shares (gift)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 40,337 shares (grant or award)
- 4 Grant or award Director acquired 31,513 shares (grant or award)
- 4 Grant or award Director acquired 26,681 shares (grant or award)
- 4 Grant or award Director acquired 15,022 shares (grant or award)
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
Page 19 of 29 · 576 filings